Evaluating the effects of Quebec's private-public drug insurance system
- PMID: 29018085
- PMCID: PMC5636629
- DOI: 10.1503/cmaj.170726
Evaluating the effects of Quebec's private-public drug insurance system
Conflict of interest statement
Competing interests: Marc-André Gagnon reports a grant from Health Canada and personal fees from Prescrire International and from the Canadian Association of Pharmacy in Oncology, all outside the submitted work. No other competing interests were declared.
Figures

References
-
- Boothe K. Ideas and the limits on program expansion: the failure of nationwide Pharmacare in Canada since 1944. Can J Polit Sci 2013;46:419–53.
-
- Morgan SG. Quebec’s drug insurance plan: a prescription for Canada? HPRU 98-2D. Vancouver: UBC Centre for Health Services and Policy Research; 1998.
-
- Pomey M-P, Forest P-G, Palley HA, et al. Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec’s universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States. Milbank Q 2007;85:469–98. - PMC - PubMed
-
- Pomey M-P, Martin E, Forest P-G. Making decisions about prescriptions drugs in Quebec: implementing the public prescription drug insurance regime in 1996–1997. Kingston (ON): Queen’s University; 2005.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources